In last trading session, Protagenic Therapeutics Inc (NASDAQ:PTIX) saw 0.12 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.55 trading at -$0.02 or -3.84% at ring of the bell on the day assigns it a market valuation of $3.97M. That closing price of PTIX’s stock is at a discount of -240.0% from its 52-week high price of $1.87 and is indicating a premium of 20.0% from its 52-week low price of $0.44. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.39 million shares which gives us an average trading volume of 272.27K if we extend that period to 3-months.

Protagenic Therapeutics Inc (NASDAQ:PTIX) trade information

Upright in the red during last session for losing -3.84%, in the last five days PTIX remained trading in the green while hitting it’s week-highest on Monday, 01/06/25 when the stock touched $0.55 price level, adding 11.15% to its value on the day. Protagenic Therapeutics Inc’s shares saw a change of 11.88% in year-to-date performance and have moved 11.88% in past 5-day. Protagenic Therapeutics Inc (NASDAQ:PTIX) showed a performance of 1.52% in past 30-days. Number of shares sold short was 89119.0 shares which calculate 1.33 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.91% during past 5 years.

Protagenic Therapeutics Inc (NASDAQ:PTIX)’s Major holders

Insiders are in possession of 14.25% of company’s total shares while institution are holding 5.77 percent of that, with stock having share float percentage of 6.73%. Investors also watch the number of corporate investors in a company very closely, which is 5.77% institutions for Protagenic Therapeutics Inc that are currently holding shares of the company.